Mortality rates among United States veterans with sarcoidosis have been rising since 2004, most notably in men, according to ...

Among those treated for sarcoidosis in the year following diagnosis, 60% used steroids alone, 13% nonsteroidal immunosuppressives alone, and 27% received both. About 43% of patients with sarcoidosis ...

Sarcoidosis is an inflammatory disease that can affect any organ in the body, although it is most commonly found in the lungs and lymph nodes. The condition is characterized by the formation of ...

Sarcoidosis is a systemic inflammatory disorder of unknown etiology, characterized by the formation of noncaseating granulomas, multisystem involvement, intrathoracic (pulmonary and lymph node ...

Sarcoidosis is an inflammatory disease characterized by the formation of granulomas in one or more organs of the body. When left unchecked, chronic inflammation caused by granulomas can lead to ...

While some patients with sarcoidosis have spontaneous disease remission, others may require treatment for symptom management, organ involvement, and/or risk reduction of disease progression.

Using skin, lung, and blood samples from sarcoidosis ... Gross Professor of Dermatology and the director of Penn's Cutaneous ...

Cantor Fitzgerald initiated coverage of aTyr Pharma (ATYR) with an Overweight rating. aTyr Pharma’s lead drug Efzofitimod is in two trials for ...

But is the disease real? Sarcoidosis is a condition where groups of cells in the immune system form small lumps called granulomas, which can appear in any organ in the body, per the U.S. National ...

The study enrolled 107 patients with pulmonary sarcoidosis considered to have chronic, active disease not well-controlled despite available therapeutic options. Patients in the study received a ...

03, 2024 (GLOBE NEWSWIRE) -- Kinevant Sciences, a clinical-stage biopharmaceutical company developing new medicines for rare inflammatory and autoimmune diseases, today announced its Phase 2 study ...